Baseline Guide Vol 8: Pharma 4.0 1st Edition

Digital

Member Price
$295.00
Non-Member Price
$670.00

Published: December 2023
Pages: 270

Applying emerging and digital technologies can lead to more robust and flexible manufacturing processes. This can help the pharmaceutical industry respond to drug shortages, reduce interruptions in the production and delivery of medicines, and ensure consistent clinical performance of products.

With the influx of new technologies on the plant floor and in the flow of work, the industry must think progressively about how organizations will work in the future. Organizations seeking to transform will embrace new technologies, move to a true end-to-end focus for their products and processes, and engage and utilize their people in new ways. Such an approach requires a systematic, systemic, and holistic transformation of the organization and its people.

However, implementing digital technologies and initiating successful digitalization projects is a challenging process. Research indicates that most organizations do not achieve their transformation objectives, and those who do have difficulty sustaining their successes.  The ISPE Baseline® Guide: Pharma 4.0™ provides the structural capabilities framework needed for realizing successful and lasting transformations. It contains tools and advice for companies in achieving their digitization and financial goals while maintaining/improving product quality and meeting regulatory requirements and expectations. In addition, this Guide outlines various starting points, prerequisites, governance structures, and strategies for achieving transformational success tailored to an organization’s size, risk tolerance, flexibility, and maturity level.

The Industrial Digital Transformation is more than just an approach to implement digital technologies; it is a shift in mindset and a fundamental shift in the way companies operate their business to deliver value for patients and customers. Smart organizations will not only have capabilities but will also be highly adaptable.

The Guide covers all areas of transformation including the benefits of a holistic control strategy, opportunities opened by digital transformation in quality management, and the foundational processes and principles for interconnected plant architecture. It includes organizational change management practices to help workers adapt to confounding challenges from new technologies and acquire the necessary skills to thrive in a changing culture. Readers will discover strategies that are revolutionizing facility design including simulation and virtualization are presented.

The Guide is a repository of technology definitions and technical principles, containing 35 real-world case studies to guide organizations exploring similar digital transformation opportunities.

And to help organizations monitor their transformation journey progress, the Guide presents the Pharma 4.0 Maturity Model and Assessment Tool.

The ISPE Baseline® Guide: Pharma 4.0™ is a valuable resource for any size company to begin, reinvigorate, or advance their transformation journey.

Baseline Guide Vol 8: Pharma 4.0 1st Edition


Guide Core Team

Nuha Al-Hafez
Quality and Compliance Advisor
Michelangelo Canzoneri
Global Head of Group Smart Manufacturing
Merck KGaA Darmstadt, Germany
Co-Lead
Yvonne Duckworth, PE
Fellow - Digital Technology, Associate
CRB
Emmie Heeren
Senior Manager Engineering
Kite Pharma
Daniele Iacovelli
SVP - Global Head of Digital, Analytics & Operational Excellence
F. Hoffmann-La Roche
Co-Lead
Paige Kane
Director Knowledge Management
MSD
Placeholder Person Graphic
Stefan Krauss
Global Partnermanager Pharma
Siemens AG
Teresa Minero
Founder & CEO
LifeBee | a ProductLifeGroup Company
Edoardo Schiraldi
Corporate Program Manager
Josef Trapl
Managing Director
Memo3 GmbH
Co-Lead
Wolfgang Winter
Software Framework R&D Director
Agilent Technologies Deutschland GmbH
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH
Co-Lead
Thomas Zimmer
VP European Operations
ISPE

For the full list of contributors to this Guide see Guidance Document Teams